Recombinant Human AIM1L Protein, GST-tagged
Cat.No. : | AIM1L-477H |
Product Overview : | Human AIM1L full-length ORF (BAA91416.1, 1 a.a. - 407 a.a.) recombinant protein with GST-tag at N-terminal. |
- Specification
- Gene Information
- Related Products
- Download
Description : | AIM1L (Absent In Melanoma 1-Like) is a Protein Coding gene. GO annotations related to this gene include carbohydrate binding. An important paralog of this gene is AIM1. |
Source : | Wheat Germ |
Species : | Human |
Tag : | GST |
Molecular Mass : | 69.6 kDa |
AA Sequence : | MEEAGGPMARAKAQVVSATLTWRQW PPTQEEIKHGFHKVSLVSGAQMEAP QKEMFEFSRREEVEVNGFATQEEET VNCQGPRDTAGSKNFQSHGPIFSKK YIPPPKEKRPEGRLKEAVDQSDGSR QAPRTEPPCVGAMARTELLVPLPGP REPSPHPGVGLTSGSSRSLEEYRVT RTVRTTTVVGGHVDRRMSSSVTVRP VSSGEALPRGRQVSRMVPPVVVGSP PGSPSRSQAVKVLSNLVPAGHSPPA SHLPRPTAGGPRSTGLGSTVGAALR QLPETGTAELKDSSALASTGIPASA HLPKNQDAPAACPDRDQGRAPDARA CELWQVLGAPSSTELPLQTSQGQAS VPSSPRLETHVPSPGLTHPAKQPVV PTHPGARLTPLVLPPKKRTGPWTPL LPPSCPW |
Applications : | Enzyme-linked Immunoabsorbent Assay Western Blot (Recombinant protein) Antibody Production Protein Array |
Notes : | Best use within three months from the date of receipt of this protein. |
Storage : | Store at -80centigrade. Aliquot to avoid repeated freezing and thawing. |
Storage Buffer : | 50 mM Tris-HCI, 10 mM reduced Glutathione, pH=8.0 in the elution buffer. |
Gene Name : | AIM1L absent in melanoma 1-like [ Homo sapiens ] |
Official Symbol : | AIM1L |
Synonyms : | AIM1L; absent in melanoma 1-like; beta gamma crystallin domain containing 2; CRYBG2; FLJ38020 |
Gene ID : | 50845 |
UniProt ID : | Q8N1P7 |
Products Types
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (14)
Ask a questionThe regulation of AIM1L expression is not yet fully understood, although some studies suggest that it is regulated by epigenetic mechanisms such as DNA methylation and histone modification.
There are currently no drugs in development that specifically target AIM1L protein. However, some drugs that target related pathways, such as cell growth and differentiation pathways, may indirectly affect AIM1L expression and function.
AIM1L protein has been studied as a biomarker for various diseases, including bipolar disorder and rheumatoid arthritis, but its diagnostic and prognostic value in these diseases is not well established.
There is limited research on the potential role of AIM1L in cardiovascular diseases, but some studies suggest that its expression may be altered in these diseases. Further research is needed to fully understand its role in cardiovascular diseases.
AIM1L protein is expressed in various tissues in the body, but its expression levels may vary depending on the tissue type and developmental stage.
There is currently no research on the therapeutic applications of AIM1L protein, but its role in tumor suppression suggests that it may have potential as a molecular target for cancer therapy.
There is limited research on the potential role of AIM1L in neurodegenerative diseases, but some studies suggest that its expression may be altered in these diseases. Further research is needed to fully understand its role in neurological disorders.
AIM1L protein has been implicated in other biological processes, including immune regulation, lipid metabolism, and glucose metabolism.
The AIM1L gene is inherited in an autosomal dominant manner, meaning that only a single copy of an altered AIM1L gene is necessary to develop certain conditions. However, there are no known conditions associated with mutations in the AIM1L gene.
There are no known protein-protein interactions between AIM1L and other proteins.
AIM1L protein can be detected and measured in the blood using ELISA (enzyme-linked immunosorbent assay) and other immunoassay techniques.
AIM1L protein has been found to be downregulated in melanoma and lung cancer, and its expression has been correlated with better prognosis and survival rates in breast cancer. Further studies are needed to fully understand its role in the development of cancer.
The levels of AIM1L protein can be measured in the blood and other bodily fluids. Its expression may be used as a diagnostic and prognostic biomarker for certain types of cancer.
AIM1L protein may be a potential target for cancer therapy, as its expression has been correlated with tumor suppression in several types of cancer. However, further research is needed to fully understand the role of AIM1L in cancer and its potential as a target for cancer therapy.
Customer Reviews (4)
Write a reviewThe bands of proteins in Western Blotting experiments were very clear.
Their dedicated team of experts is always readily available to address any challenges or inquiries that may arise during my experiments.
Its unparalleled purity, stability, and efficacy ensure the utmost reliability and accuracy in my research, propelling my investigations to new levels of precision and insight.
I am particularly impressed by the manufacturer's commitment to delivering excellent technical support.
Ask a Question for All AIM1L Products
Required fields are marked with *
My Review for All AIM1L Products
Required fields are marked with *
Inquiry Basket